Automatic monitoring of adverse drug reaction of anti-tuberculosis and analysis of influencing factors
10.13699/j.cnki.1001-6821.2024.07.026
- VernacularTitle:抗结核药物的药品不良反应自动监测研究及其影响因素分析
- Author:
Kai ZHANG
1
;
Xiao-Qin LU
;
Zhi DONG
Author Information
1. 重庆医科大学药学院,重庆 400016
- Keywords:
first-line anti-tuberculosis drug;
tuberculosis;
automatic monitoring system;
adverse drug reaction;
influencing factor
- From:
The Chinese Journal of Clinical Pharmacology
2024;40(7):1059-1062
- CountryChina
- Language:Chinese
-
Abstract:
Objective To provide reference for clinical rational drug use,the adverse drug reaction(ADR)automatic monitoring system was used to monitor ADR in patients treated with first-line anti-tuberculosis drugs.Methods A total of 1 147 tuberculosis patients hospitalized in the infection department of our hospital from 2019 to 2022 were selected to monitor the occurrence of ADR during the hospitalization.Univariate and multivariate analysis were used to study the risk factors affecting the incidence of ADR.Results After systematic screening and pharmacist review,a total of 598 cases of ADR related to first-line anti-tuberculosis drugs were found,with an incidence of 52.14％.ADR mainly affects the endocrine system,digestive system,and hepatobiliary system.The incidence of ADR in oral isoniazid is higher than that in intravenous drip and nebulization routes.The results of multivariate regression analysis showed that women and a history of hepatitis were independent risk factors for the occurrence of ADR(all P＜0.05).Conclusion The incidence of ADR with anti-tuberculosis drugs is high.Women and patients with a history of hepatitis are high-risk groups for adverse drug reactions to anti-tuberculosis drugs.In clinical,safer drugs should be selected for such patients,and the occurrence of ADR should be closely monitored to reduce the impact of ADR on the treatment process.
